Arbutus Biopharma Corp

NASDAQ:ABUS 4:00:00 PM EDT

2.48

+0.15 (+6.44%)

7:35:06 PM EDT: $2.50 +0.02 (+0.81%)

Market Cap (Intraday)	413.03M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$6.18 Million
Adjusted EPS	-$0.13

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

Arbutus Biopharma Corp Stock, NASDAQ:ABUS

701 Veterans Circle, Suite 100, Warminster, Pennsylvania 18974

Phone: +1.267.469.0914

Number of Employees: 87

http://www.arbutusbio.com

Description

Arbutus Biopharma Corp. is a biopharmaceutical company. It engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded in 2007 and is headquartered in Warminster, PA.